MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ELDN has $169,009K in assets. $32,230K in debts. $22,808K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
739.69%
Quick Ratio
739.69%
Cash Ratio
124.33%
Debt to Asset Ratio
19.07%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • In-process research and developm...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible preferred stock, val...
    • Others

Balance Sheets
2025-12-31
2024-12-31
Cash and cash equivalents
22,808 20,549
Short-term investments
110,528 119,629
Prepaid expenses and other current assets
2,352 3,552
Total current assets
135,688 143,730
Operating lease right-of-use asset, net
613 926
In-process research and development
32,386 32,386
Other assets
322 363
Total assets
169,009 177,405
Accounts payable
3,627 5,833
Current operating lease liability
358 314
Accrued expenses and other liabilities
14,359 5,430
Total current liabilities
18,344 11,577
Deferred tax liability
2,187 2,183
Non-current operating lease liability
283 640
Warrant liabilities
11,416 44,865
Total liabilities
32,230 59,265
Convertible preferred stock, value-Series XNon Voting Convertible Preferred Stock
2,151 2,151
Convertible preferred stock, value-Series X1Non Voting Convertible Preferred Stock
53,543 53,543
Common stock, 0.001 par value, 300,000,000 and 200,000,000 shares authorized at december 31, 2025 and 2024, respectively 75,430,033 and 59,789,275 shares issued and outstanding at december 31, 2025 and 2024, respectively
75 60
Additional paid-in capital
482,189 417,946
Accumulated other comprehensive income
24 26
Accumulated deficit
-401,203 -355,586
Total stockholders' equity
81,085 62,446
Total liabilities, convertible preferred stock and stockholders' equity
169,009 177,405
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$110,528K (-7.61%↓ Y/Y)Cash and cashequivalents$22,808K (10.99%↑ Y/Y)Prepaid expenses andother current assets$2,352K (-33.78%↓ Y/Y)Total current assets$135,688K (-5.60%↓ Y/Y)In-process research anddevelopment$32,386K (0.00%↑ Y/Y)Operating leaseright-of-use asset, net$613K (-33.80%↓ Y/Y)Other assets$322K (-11.29%↓ Y/Y)Total assets$169,009K (-4.73%↓ Y/Y)Total liabilities,convertible preferred stock...$169,009K (-4.73%↓ Y/Y)Total stockholders'equity$81,085K (29.85%↑ Y/Y)Convertible preferredstock, value-Series...$53,543K (0.00%↑ Y/Y)Total liabilities$32,230K (-45.62%↓ Y/Y)Convertible preferredstock, value-Series...$2,151K (0.00%↑ Y/Y)Accumulated deficit-$401,203K (-12.83%↓ Y/Y)Additional paid-in capital$482,189K (15.37%↑ Y/Y)Total currentliabilities$18,344K (58.45%↑ Y/Y)Warrant liabilities$11,416K (-74.55%↓ Y/Y)Deferred tax liability$2,187K (0.18%↑ Y/Y)Non-current operating leaseliability$283K (-55.78%↓ Y/Y)Common stock, 0.001 parvalue, 300,000,000 and...$75K (25.00%↑ Y/Y)Accumulated othercomprehensive income$24K (-7.69%↓ Y/Y)Accrued expenses andother liabilities$14,359K (164.44%↑ Y/Y)Accounts payable$3,627K (-37.82%↓ Y/Y)Current operating leaseliability$358K (14.01%↑ Y/Y)

Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals, Inc. (ELDN)